Science Explorer Interactive view Map
Company · Waltham · United States

TScan Therapeutics (United States)

tscan.comROR OpenAlex
Research works
22
fractional, all time
Citations
333
15.0 per fractional work
Top-10% rate
5.6%
record average 16.5%
Open access
68%
world 28%

Not ranked overall: TScan Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at TScan Therapeutics (United States)?

Ranked on the composite score, Gavin MacBeath lead among researchers whose main affiliation is TScan Therapeutics (United States).

  1. 1 Gavin MacBeath United States · #628,545 worldwide 99 citations · 25 works
All ranked researchers at TScan Therapeutics (United States)

Which keywords describe research at TScan Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, CAR T Cells, Chimeric Antigen Receptor, Antigen Presentation, Immunity and Dendritic Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 14 words, with their numbers
  1. Cancer Immunotherapy13▲ 404×2 topics
  2. Immunotherapy9▲ 65×3 topics
  3. CAR T Cells9▲ 961×1 topic
  4. Chimeric Antigen Receptor9▲ 961×1 topic
  5. Tumor Regression9▲ 480×2 topics
  6. Antigen Presentation4▲ 170×2 topics
  7. Immunity4▲ 49×2 topics
  8. Dendritic Cells3▲ 129×1 topic
  9. Tumor Antigen3▲ 183×1 topic
  10. Monoclonal Antibodies2▲ 57×3 topics
  11. Glycosylation2▲ 35×2 topics
  12. Antibody Engineering1▲ 59×1 topic
  13. Fc Receptors1▲ 59×1 topic
  14. Therapeutic Antibodies1▲ 47×2 topics

Which research topics does TScan Therapeutics (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research and Cancer Immunotherapy and Biomarkers.

CAR-T cell therapy resea…8CAR-T cell therapy research: 8 fractional worksImmunotherapy and Immune…2Immunotherapy and Immune Responses: 2 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksViral Infectious Diseases and Gene Expression in Insects: 0 fractional worksVirus-based gene therapy research: 0 fractional worksvaccines and immunoinformatics approaches: 0 fractional worksT-cell and B-cell Immunology: 0 fractional worksCell Adhesion Molecules Research: 0 fractional works
OncologyImmunologyRadiology, Nuclear Medicine and ImagingMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 8 works
  2. 2 Immunotherapy and Immune Responses Immunology 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
  5. 5 Biosimilars and Bioanalytical Methods Immunology 0 works
  6. 6 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  7. 7 Virus-based gene therapy research Genetics 0 works
  8. 8 vaccines and immunoinformatics approaches Molecular Biology 0 works
  9. 9 T-cell and B-cell Immunology Immunology 0 works
  10. 10 Cell Adhesion Molecules Research Immunology and Allergy 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available68.4%not open31.6%

World: 28% of research is openly available.

with international co-authors11.0%domestic only89.0%

World: 19% is written across borders.

How has TScan Therapeutics (United States)'s research output changed?

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Waltham

All research institutions in Waltham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.